Undated -- Frank Reynolds founded InVivo Therapeutics in 2005 and serves as Chairman of the Board, CEO and CFO.
Frank suffered a paralyzing injury to his spine in December 1992. While recovering from this injury, he spent years gaining subject matter expertise on the spine and spinal cord.
A new technology created by InVivo Therapeutics could mean a cure for paralysis in the near future.
InVivo Therapeutics Holdings Corp is a Cambridge, Massachusetts medical device company focused on utilizing polymers as a platform technology to develop and commercialize groundbreaking treatments for spinal cord injuries.
Currently, there are no successful treatment options for spinal cord injuries. InVivo's technology basically minimizes tissue damage after a spinal cord injury, thus improving the chance of walking again.
It involves inserting a polymer-based medical device (scaffold) into the area where the spine was injured. In studies already conducted, two paralyzed monkeys are videotaped unable to move...after two days the monkey is walking.
These results have been duplicated time and time again in animal studies and the company is now set to begin studies on humans.
Ultimately, this could be the cure to paralysis in most spinal injury cases. It costs a patient $3 million to treat it during a life time, $1 million in the first year alone. InVivo's new device cuts that cost down by 80%. InVivo plans to complete human trials and make this revolutionary treatment available to anyone with a spine injury.